4/10/2025Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...

4/10/2025China Unveils Ambitious Plan to Boost Health-Related Consumption

4/10/2025Sumitomo Pharma Transfers Asian/Chinese Operations Amid Industry-Wide ...

4/10/2025XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...

4/9/2025China Launches Phase I Trial for Nation's First Monkeypox Vaccine

4/9/2025U.S. Urged to Boost Biotech Investment to Counter China's Strategic Ad...

4/9/2025RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG

4/8/2025TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China

4/8/2025Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...

4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...

4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses

4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...

4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...

4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations

4/5/2025Recent Executive Moves

4/5/2025China Biopharma Licensing Tracker, Q1 2025 (MC)

4/5/2025China Biopharma Financing Tracker, Q1 2025 (MC)

4/1/2025China's Pharma Industry Shows Signs of Recovery After Economic Downtur...

4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy

4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China

3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...

3/31/2025BMS's Opdivo and Yervoy Combio Approved in China

3/31/2025Roche's Ocrevus Receives Chinese Approval for MS

3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib

3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...

3/28/2025Recent Executive Moves

3/27/2025Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)

3/27/2025China to Spur Innovation through New Reimbursement List (ThePharmaLett...

3/26/2025Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346

3/26/2025NMPA Holds 2025 National Drug Regulatory Policy and Law Conference

Page:3/356 Total number of articles:10655: [First][<<] [1] [2] [3] [4] [5] [>>] [End]